Tsev / Cov khoom / Peptides / Paub meej
video
Semaglutide hmoov

Semaglutide hmoov

Cov tsos mob: Dawb los tawm cov hmoov dawb
Specification: 98% min
CAS Nr .: 910463-68-2
Cov roj formula: C187H291N45O59
Molecular Luj: 4113.57754
PIB: 203-405-2
Txee Lub neej: 2 Xyoo Kev Cia Siab
Tshuag: Cov Tshuag Tshiab
Daim ntawv pov thawj: COA, GMP, ISO, HACCP
Kev Pabcuam: OEM & ODM Kev Pabcuam

Khoom Taw qhia

Semaglutide hmoov GMP Chaw tsim tshuaj paus nyob rau hauv Suav teb|Siab -Purity GLP-1 Receptor Agonist API rau Metabolic Research Bulk Supply

Nta:

✅ Ntev 160h ib nrab -lub neej, zoo tagnrho rau kev tshawb fawb noj txhua lub lim tiam

✅ Glucose - nyob ntawm kev tswj glycemic nrog qis qis qis qis

✅ Ua kom qab los noj mov thiab plab hnyuv qeeb qeeb rau kev kawm hnyav

✅ Kev tiv thaiv kab mob cardio, lub raum thiab lub siab metabolic

✅ 2-xyoo ruaj khov lub neej nrog kev ua tiav bioactivity

✅ Cov ntaub ntawv tseem ceeb (COA, HPLC, LC-MS, MSDS) muaj

 

Semaglutide Powder yog dab tsi thiab nws ua haujlwm li cas ntawm GLP-1 Analog?

 

Semaglutide hmoov (CAS: 910463-68-2)yog ib lub sijhawm ntev - ua yeeb yam GLP-1 receptor agonist peptide tsim los rau kev tshawb fawb metabolic thiab tshuaj siv tshuaj. Nws sib koom ua ke zoo sib xws nrog endogenous GLP-1 thaum koom nrog kev hloov kho cov qauv uas txhawb nqa nws txoj kev nyab xeeb thiab lub sijhawm ua haujlwm.

 

Cov khoom yog muab los ua dawb peptide API tsim los ntawm cov khoom siv -theem peptide synthesis (SPPS), tom qab los ntawm ntau- kauj ruam chromatographic purification thiab lub tshuab nqus tsev khov - ziab.

Kev tsim kho kom zoo nkauj muaj xws li:

Aib hloov ntawm txoj hauj lwm 8 los txo cov enzymatic degradation (DPP-4 tsis kam)

C18 fatty acid side chain conjugation ntawm lysine 26 txhawm rau txhim kho albumin khi thiab ua kom ntev lub sijhawm

 

COA Quality Specifications for Semaglutide Powder yog dab tsi?

 

Yam khoom Specification Kev tshwm sim
Qhov tshwm sim Cov khoom no yog dawb los tawm cov hmoov dawb, Cov khoom no yog dawb soluble hauv dej Ua raws
Cov ntsiab lus dej Tsawg dua lossis sib npaug li 8.0% 0.032
p H pH yuav tsum yog 6.0 txog 8.0 7.2
Clarity thiab xim ntawm kev daws Cov tshuaj yuav tsum yog ntshiab thiab tsis muaj xim Ua raws
Acetic acid Tsawg dua los yog sib npaug li 0.5% ND
Trifluoroacetic acid Tsawg dua lossis sib npaug li 0.1% 0.003%
sodium ion Tsawg dua lossis sib npaug li 5.0% 1.90%
Residual kuab tshuaj Methyl tert-butyl ether Tsawg dua lossis sib npaug li 0.5% 0.001%
Methanol Tsawg dua lossis sib npaug li 0.3% 0.001%
Acetonitrile Tsawg dua lossis sib npaug rau 0.041% 0.004%
1-Methyl-2-pyrrolidinone Tsawg dua lossis sib npaug rau 0.053% 0.001%
[des+Gly³¹]Semaglutid Tsawg dua lossis sib npaug li 0.5% 0.09%
[ -Asp⁹Semaglutide Tsawg dua lossis sib npaug li 0.5% 0.05%
[Ile² Semaglutide Tsawg dua lossis sib npaug rau 0.5% 0.03%
[des + Gly⁴Semaglutide Tsawg dua lossis sib npaug li 0.5% 0.13%
[Lys²⁰(AEEA-AEEA- -Glu-Octadecanedioic)]
Semaglutide Tsawg dua lossis sib npaug li 0.5%
0.10%
Lwm tus neeg impurities yuav tsum tsawg dua lossis sib npaug li 0.5% Tsawg dua lossis sib npaug li 0.13%
Tag nrho impurities Tsawg dua lossis sib npaug li 2.0% 0.67%
Purity Ntau dua lossis sib npaug li 98.0% 99.40%
Cov kab mob endotoxin Tus nqi ntawm endotoxin hauv txhua 1mg ntawm Semaglutide
yuav tsum tsawg dua 3EU
0.04e ua
Siab molecular
hnyav tshuaj
Tsawg dua lossis sib npaug li 0.3% 0.01%
Assay Muaj Semaglutide (C₁₇H₂₀N₄₃O,)
95.0%-105.0%
100.80%
Kev ntsuam xyuas ntawm Peptide >80.0% 94.30%
Xaus Cov khoom ua tau raws li qhov yuav tsum tau ua

 

Dab tsi yog Kev Tshawb Fawb -Cov txiaj ntsig zoo ntawm Semaglutide Hmoov?

 

1. Nws tswj cov piam thaj metabolism li cas?

Semaglutide hmoovtxhim kho cov piam thaj- nyob ntawm insulin secretion thiab inhibits glucagon tso tawm, pab txhawb kev yoo mov thiab kev tswj ntshav qabzib tom qab uas tsis tshua muaj kev pheej hmoo ntawm hypoglycemia.

2. Nws cuam tshuam li cas rau kev qab los noj mov thiab lub cev hnyav?

Nws ua rau txoj hauv kev hypothalamic kom txo qis qab los noj mov, ua rau lub plab zom mov qeeb, thiab ua rau kom satiety, ua rau txo cov calories kom tsawg hauv cov qauv rog.

3. Puas muaj kev cuam tshuam rau cov hlab plawv?

Preclinical thiab soj ntsuam cov kev tshawb fawb qhia tau hais tias txhim kho endothelial muaj nuj nqi, txo inflammatory markers, thiab tej zaum yuav txo tau nyob rau hauv cov teeb meem loj ntawm cov hlab plawv.

4. Cov txheej txheem tiv thaiv lub raum tau kawm li cas?

Nws tuaj yeem ua rau qeeb ntawm kev mob ntshav qab zib nephropathy los ntawm kev txo qis glomerular kev ntxhov siab thiab txhim kho cov metabolism hauv cov kab mob raum.

5. Nws cuam tshuam li cas rau daim siab metabolism?

Nws txo cov lipogenesis ntawm lub siab thiab cov rog tsub zuj zuj, txhawb kev tshawb fawb hauv metabolic dysfunction -sociated steatotic siab kab mob (MASLD).

6. Nws puas muaj peev xwm tiv thaiv neuroprotective?

Qee qhov kev tshawb fawb qhia txog ntshav- lub hlwb thaiv kev nkag mus thiab muaj peev xwm ua taus ntawm oxidative stress regulation thiab neuronal survival pathways.

 

Dab tsi yog Daim Ntawv Thov ntawm Semaglutide Powder?

 

  • Nyob rau hauv vitro GLP-1 receptor signaling pathway kev tshawb fawb hauv cov chaw soj nstuam kev kawm
  • Tsiaj qauv ntawm kev rog rog, ntshav qab zib, thiab rog rog daim siab
  • Kev loj hlob ntawm ntev - ua yeeb yam tshuaj peptide formulations
  • Cardiometabolic thiab neurodegenerative kab mob preclinical kev tshawb fawb
  • Peptide stability, kev xa khoom, thiab kev txhawb nqa - tso tawm cov kev tshawb fawb txog kev tsim
  • Siv cov khoom siv rau kev soj ntsuam zoo tswj lub chaw soj nstuam

 

Vim Li Cas Xaiv Peb Semaglutide Powder Manufacturing Supply?

 

  • Tight batch-rau-batch purity control with variation<0.3%
  • Txuas ntxiv ib nrab -lub neej molecular tsim los txhawb txo cov qauv siv ntau zaus
  • Siab - ruaj khov lyophilized formulation nrog ntev - lub sij hawm cia kev ncaj ncees
  • Tag nrho cov ntaub ntawv GMP suav nrog COA, MSDS, thiab TDS
  • Kev xaiv ntim tau yooj yim los ntawm milligram mus rau kilogram nplai
  • Kev ntseeg siab thoob ntiaj teb txias-chain logistics nrog kub- tswj kev thauj khoom
  • Dedicated technical support rau peptide tuav thiab formulation qhia

 

Dab tsi yog Mechanism of Action of Semaglutide Powder?

Peripheral metabolic mechanism

  • Activates GLP-1 receptors ntawm pancreatic -cells
  • Txhim kho cov piam thaj -nyob ntawm cov tshuaj insulin secretion
  • Txhawb nqa glucagon secretion los ntawm -cells
  • Txo cov piam thaj hauv siab tso zis thiab lipid synthesis
  • Ncua lub plab khoob kom txo tau cov as-ham nqus

Central paj hlwb mechanism

  • Hla cov ntshav- hlwb barrier
  • Activates hypothalamic satiety chaw zov me nyuam
  • Txo qhov qab los noj mov- cuam tshuam txog cov teeb liab neuropeptide
  • Modulates oxidative kev nyuaj siab thiab neuronal ciaj sia txoj kev

Tus qauv stability mechanism

  • Kev hloov pauv Aib tiv thaiv kev degradation sai sai
  • Fatty acid side chain enables albumin binding
  • Txuas plasma ib nrab - lub neej mus rau kwv yees li 160 teev

 

Qhov System Assurance System yog dab tsi?

 

  • Multi-theem zoo tswj: crude → nruab nrab → khoom kawg
  • Dual analytical validation siv HPLC thiab LC-MS
  • Khaws cia batch qauv system rau tag nrho traceability
  • GMP-ua raws li qhov chaw tsim khoom huv huv
  • Thib peb -kev xeem sib raug zoo rau kev pov thawj ywj pheej
  • Txias-chain logistics nrog kev ntsuas kub tsis tu ncua

 

FAQ

 

Q: Puas yog semaglutide tib yam li Ozempic?

A: Ozempic yog ib hom tshuaj txhaj tshuaj semaglutide; Semaglutide yog cov tshuaj active tshuaj.

 

Q: Ntev npaum li cas kom poob 30 phaus ntawm semaglutide?

A: Feem ntau 3-6 lub hlis nrog kev hloov kho lub neej, sib txawv ntawm tus kheej.

 

Q: Dab tsi yog qhov downside ntawm semaglutide?

A: Cov kev mob tshwm sim tseem ceeb yog GI tsis xis nyob; Nws muaj contraindications rau cov neeg uas muaj qee yam thyroid lossis pancreatitis keeb kwm.

 

Q: Semaglutide yog dab tsi rau qhov hnyav - poob?

A: GLP-1 tshuaj uas txwv kev tshaib kev nqhis los pab tswj qhov hnyav mus ntev rau cov neeg siv rog rog / rog rog.

 

Hoobkas

Semaglutide-Powder-GMP-Manufacturing-Cleanroom-API-Production-Workshop-China.webp

Semaglutide-Powder-SPPS-Synthesis-Fmoc-Strategy-HPLC-Quality-Control-Laboratory.webp

Semaglutide-Powder-Bulk-Manufacturing-Facility-Stainless-Steel-Reactor-Pharmaceutical-Plant.webp

 

Daim ntawv pov thawj

Semaglutide-Powder-COA-HPLC-MS-Test-Report-Quality-Analysis-GMP-Certified-Batch.webp

Semaglutide-Powder-GMP-ISO-Certification-Pharmaceutical-Quality-Compliance-Document.webp

Shipping & Packing

 

Semaglutide-Powder-Lyophilized-White-Powder-Sealed-Vial-Bulk-Packaging-China-Supplier.webp

 

Kev xa khoom ntau & Kev nug

 

Peb muab qib siab -purity GMP- qibSemaglutide hmoovrau cov koom haum tshawb fawb thoob ntiaj teb, cov kws tsim tshuaj, thiab cov chaw soj ntsuam.

Yog tias koj tab tom nrhiav qhov chaw ruaj khov, zoo -cov ntaub ntawv GLP-1 receptor agonist rau kev tshawb fawb daim ntawv thov, peb cov txheej txheem tsim khoom ua kom zoo ib yam thiab muaj peev xwm ua tau.

 

Rau cov lus hais, cov qauv, lossis cov ntaub ntawv thev naus laus zis, thov hu rau:

WhatsApp: +8619991242181
Email:sales@hdmbio.com

Cim npe nrov: Tuam Tshoj semaglutide hmoov manufacturers, lwm tus neeg, Hoobkas

Xa kev nug

Tsev

Xov tooj

Tug

Kev nug

hnab